Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
1.
J Mycol Med ; 31(1): 101081, 2021 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-33360730

RESUMEN

OBJECTIVE: This study aimed at providing original data on fungemia in the Centre Hospitalier de Mayotte in terms of prevalence, epidemiological characteristics of infected patients, yeast species distribution and profile of in vitro antifungals susceptibility. METHODS: A total of 223 positive blood cultures for yeasts were retrospectively reported during the period April 2010-April 2020. RESULTS: Ninety-five episodes were identified corresponding to an incidence rate of 3.7 cases/100,000 inhabitants. The average age of patients was 33.5 years, and 63.3% patients were hospitalized in intensive care unit. The main co-morbidities were surgery in the 30 days prior to fungemia (27.8%), neoplasia (22.8%), parenteral nutrition (17.7%), diabetes (16.5%) and immunosuppressive medications (31.6%). Candida spp accounted for the majority of isolates (92.4%) with a predominance of non-albicans species (55.8% vs 33.7%), including C. albicans (33.7%), C. tropicalis (30.5%) and C. parapsilosis (20%). The antifungal susceptibility profiles did not differ from expected results for each species and did not change significantly over time. DISCUSSION: Fungemia remain frequent hospital infections associated with high mortality in Mayotte. The vast majority of fungemia was due to Candida spp. Non-albicansCandida species reach half of the Candida isolates with a high percentage of C. tropicalis. Surprisingly, no case of candidemia due to C. glabrata were identified. The management of candidemia remains satisfactory and the treatment was adapted according to the international recommendations. However, the high susceptibility of Candida spp. isolates to fluconazole may invite to reconsider the use of this molecule as empirical and first-line treatment of candidemia in Mayotte.


Asunto(s)
Antifúngicos/farmacología , Candida/clasificación , Candida/efectos de los fármacos , Infección Hospitalaria/epidemiología , Fungemia/epidemiología , Fungemia/microbiología , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Antifúngicos/uso terapéutico , Candida/aislamiento & purificación , Niño , Preescolar , Comoras/epidemiología , Farmacorresistencia Fúngica , Femenino , Francia , Fungemia/tratamiento farmacológico , Humanos , Incidencia , Océano Índico , Lactante , Recién Nacido , Masculino , Pruebas de Sensibilidad Microbiana , Persona de Mediana Edad , Estudios Retrospectivos , Adulto Joven
2.
Rev Infect Dis ; 12 Suppl 8: S929-39, 1990.
Artículo en Inglés | MEDLINE | ID: mdl-2270415

RESUMEN

The etiology of acute lower respiratory tract infection (ALRI) was identified in 235 (43.8%) of 537 hospitalized children less than 5 years of age. Clinical evidence of measles was found in 258 (48.0%) patients, of whom 59 had a second viral infection. A viral agent was identified in an additional 121 patients, so that a total of 379 (70.6%) had viral infections. After measles, respiratory syncytial virus was the most common respiratory virus. Bacteremia was noted in 72 children (13.4%), occurring as frequently in children with measles (14.8%) as in those without (12.1%); Haemophilus influenzae and Salmonella typhi were predominant in the former, and H. influenzae, Staphylococcus aureus, and Streptococcus pneumoniae were prominent in the latter. The presence of bacterial antigen in urine was not helpful in identifying bacterial infection. Extrapulmonary and intrapleural complications, concomitant measles, complicated ALRI, female gender, and malnutrition were associated with increased mortality among children with ALRI. The importance of measles immunization, vitamin A supplementation for alleviation of defects associated with malnutrition, and timely antimicrobial therapy is emphasized.


Asunto(s)
Infecciones Bacterianas/etiología , Infecciones del Sistema Respiratorio/etiología , Virosis/etiología , Enfermedad Aguda , Factores de Edad , Antígenos Bacterianos/orina , Infecciones Bacterianas/epidemiología , Infecciones Bacterianas/mortalidad , Preescolar , Femenino , Humanos , Lactante , Recién Nacido , Masculino , Estado Nutricional , Filipinas/epidemiología , Estudios Prospectivos , Infecciones del Sistema Respiratorio/epidemiología , Infecciones del Sistema Respiratorio/mortalidad , Factores de Riesgo , Prueba Bactericida de Suero , Virosis/epidemiología , Virosis/mortalidad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA